IP Group’s (IPO) Buy Rating Reiterated at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reaffirmed their buy rating on shares of IP Group (LON:IPO) in a report issued on Wednesday morning,Digital Look reports. The firm currently has a GBX 110 price target on the stock.

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 119 price target on shares of IP Group in a research note on Tuesday. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of GBX 114.50.

IP Group Trading Down 0.3%

LON IPO opened at GBX 69.80 on Wednesday. IP Group has a one year low of GBX 48 and a one year high of GBX 75. The company has a debt-to-equity ratio of 11.90, a current ratio of 36.57 and a quick ratio of 8.59. The firm has a market cap of £616.63 million, a P/E ratio of 9.83 and a beta of 1.27. The stock’s 50-day moving average is GBX 68.03 and its 200-day moving average is GBX 63.22.

IP Group (LON:IPO) last issued its quarterly earnings data on Tuesday, September 15th. The company reported GBX 3.53 earnings per share (EPS) for the quarter. IP Group had a return on equity of 14.25% and a net margin of 321.64%. Sell-side analysts anticipate that IP Group will post 19.6245031 earnings per share for the current fiscal year.

Insider Buying and Selling at IP Group

In other news, insider Greg Smith acquired 45,000 shares of IP Group stock in a transaction dated Wednesday, August 5th. The stock was bought at an average cost of GBX 68 per share, with a total value of £30,600. Also, insider Michael Queen acquired 200,000 shares of IP Group stock in a transaction dated Tuesday, August 4th. The shares were purchased at an average cost of GBX 66 per share, with a total value of £132,000. Insiders have bought 271,368 shares of company stock valued at $18,053,024 in the last 90 days. 1.57% of the stock is currently owned by company insiders.

IP Group Company Profile

IP Group accelerates the impact of science for a better future. As the most active UK based, early-stage science investor, we develop and support some of the world’s most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK’s largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach.